Now a new study—presented at the Heart Failure 2013 conference in Lisbon, Portugal—has shown that supplementing with CoQ10 can cut mortality rates in half in patients of moderate to severe heart failure.
The double-blind, placebo-controlled Q-SYMBIO study split 420 patients into two groups. One group received 100 mg of CoQ10 three times a day, while the placebo group received no CoQ10.
After two years, 25% of the placebo group had a major adverse cardiovascular event (MACE), compared to 14% of the in the group receiving CoQ10. Mortality and hospitalizations were also lower in the CoQ10 group, with 18 people dying in the study group, vs. 36 in the placebo group.
According to lead author, Professor Svend Aage Mortensen from Copenhagen University Hospital’s Heart Centre in Denmark, “CoQ10 is the first drug to improve heart failure mortality in over a decade and should be added to standard treatment… Supplementation with CoQ10, which is a natural and safe substance, corrects a deficiency in the body and blocks the vicious metabolic cycle in chronic heart failure called the energy starved heart.” (European Society of Cardiology Press Release, May 25, 3013)
With CoQ10 supplements, you want to look for the ubiquinol form. Ubiquinol is the form of CoQ10 your body can use and absorb right away.